Novo Holdings is a holding and investment company that is responsible for managing the assets and the wealth of the Novo Nordisk Foundation, one of the world’s largest enterprise foundations. Novo Holdings is the controlling shareholder of Novo Nordisk and Novonesis (the Novo Group companies) and manages an investment portfolio with a long-term return perspective. Novo Holdings invests in life science companies at all stages of development and, in addition, manages a broad portfolio of equities, bonds, real estate and infrastructure assets as well as private equity investments. As of year-end 2024, Novo Holdings had Total Assets under Management of DKK 1,060bn (€142bn).
The company operates from offices in Copenhagen, London, San Francisco, Boston, Singapore and Shanghai. We recruit candidates from diverse backgrounds who embrace a culture of high performance with respect and responsibility. Our mission is to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation, while we act as a responsible owner of the Novo Group and broader investor across Seed, Venture, Growth, Principal Investments, Planetary Health Investments and Asia initiatives.